Phase 3 chronic cough Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Refractory Chronic CoughCough
Bellus Health Inc. - a GSK company975 enrolled242 locationsNCT05600777
Not Yet Recruiting
Phase 2Phase 3
Pregabalin for the treatment of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) associated chronic cough.
Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)chronic cough
Richard Roxburgh18 enrolled1 locationACTRN12623001356651
Completed
Phase 3
Pregabalin and Speech Pathology Treatment for Chronic Cough
Idiopathic and Refractory Chronic Cough
John Hunter Hospital56 enrolled1 locationACTRN12611001186943
Completed
Phase 3
The role of Gabapentin in the treatment of refractory chronic dry cough.
chronic cough
Hunter New England Area Health Service56 enrolled1 locationACTRN12608000248369